Published in Proc Natl Acad Sci U S A on May 01, 1987
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A (2001) 11.06
A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci U S A (1988) 7.47
Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J (1992) 5.23
Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc Natl Acad Sci U S A (1987) 5.06
The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J (1989) 4.27
Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J (1992) 3.98
c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J (1999) 3.65
Characterization of junD: a new member of the jun proto-oncogene family. EMBO J (1989) 3.55
jun-D: a third member of the jun gene family. Proc Natl Acad Sci U S A (1989) 3.47
Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly. Proc Natl Acad Sci U S A (1990) 3.31
The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO J (1989) 3.17
Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol (1994) 3.15
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci U S A (2001) 3.01
Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci U S A (1988) 2.92
Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol Cell Biol (1993) 2.73
Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc Natl Acad Sci U S A (1988) 2.51
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Mol Cell Biol (1990) 2.38
The cross-pathway control gene of Neurospora crassa, cpc-1, encodes a protein similar to GCN4 of yeast and the DNA-binding domain of the oncogene v-jun-encoded protein. Proc Natl Acad Sci U S A (1988) 2.35
v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci U S A (1989) 2.24
The O2 gene which regulates zein deposition in maize endosperm encodes a protein with structural homologies to transcriptional activators. EMBO J (1989) 2.20
Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Mol Cell Biol (1990) 2.16
Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene. Proc Natl Acad Sci U S A (1989) 2.13
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Natl Acad Sci U S A (2002) 2.11
Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol Cell Biol (1991) 1.91
Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc Natl Acad Sci U S A (1988) 1.88
GATA Transcription Factors and Cancer. Genes Cancer (2010) 1.88
A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J (2003) 1.83
Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer (2010) 1.76
The basic region of Fos mediates specific DNA binding. EMBO J (1989) 1.75
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol (1989) 1.70
Expression of raf oncogenes activates the PEA1 transcription factor motif. Mol Cell Biol (1989) 1.66
Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc Natl Acad Sci U S A (1988) 1.65
Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain. Proc Natl Acad Sci U S A (1992) 1.60
The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol Cell Biol (1991) 1.59
The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J (1995) 1.55
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J (2000) 1.49
Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol Cell Biol (1995) 1.48
Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev (1998) 1.42
Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt. Int J Cancer (2009) 1.36
3' junctions of oncogene-virus sequences and the mechanisms for formation of highly oncogenic retroviruses. J Virol (1993) 1.36
The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J (1989) 1.35
Empty spiracles, a gap gene containing a homeobox involved in Drosophila head development. EMBO J (1992) 1.33
Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene. J Virol (1989) 1.27
Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions. J Virol (1990) 1.25
Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. Mol Cell Biol (1991) 1.23
Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci U S A (2008) 1.22
Overexpression of c-jun, junB, or junD affects cell growth differently. Proc Natl Acad Sci U S A (1991) 1.21
Transcriptional regulation of the c-jun gene by retinoic acid and E1A during differentiation of F9 cells. EMBO J (1992) 1.20
Analysis of AP-1 function in cellular transformation pathways. J Virol (1994) 1.18
Trans-dominant negative mutants of Fos and Jun. Proc Natl Acad Sci U S A (1990) 1.18
DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest (2012) 1.18
Nuclear protein phosphorylation and growth control. Biochem J (1992) 1.16
Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation. Proc Natl Acad Sci U S A (1992) 1.15
c-Jun, at the crossroad of the signaling network. Protein Cell (2011) 1.14
c-Jun-deficient cells undergo premature senescence as a result of spontaneous DNA damage accumulation. Mol Cell Biol (2004) 1.13
v-jun is a transcriptional activator, but not in all cell-lines. Nucleic Acids Res (1988) 1.12
Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation. Bioorg Med Chem Lett (2009) 1.11
Retroviral oncogenes: a historical primer. Nat Rev Cancer (2012) 1.10
Localization of the human JUN protooncogene to chromosome region 1p31-32. Proc Natl Acad Sci U S A (1988) 1.10
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway. Proc Natl Acad Sci U S A (2003) 1.09
Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc Natl Acad Sci U S A (1999) 1.09
Insertional oncogenesis by non-acute retroviruses: implications for gene therapy. Viruses (2011) 1.09
Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. Cancer Res (2009) 1.08
AP-1 and colorectal cancer. Inflammopharmacology (2005) 1.07
Activation of junB by PKC and PKA signal transduction through a novel cis-acting element. Nucleic Acids Res (1991) 1.04
The cell cycle-dependent nuclear import of v-Jun is regulated by phosphorylation of a serine adjacent to the nuclear localization signal. J Cell Biol (1995) 1.03
Energy transfer analysis of Fos-Jun dimerization and DNA binding. Proc Natl Acad Sci U S A (1994) 1.02
Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila. EMBO J (2004) 1.01
Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci U S A (2004) 1.01
Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J Virol (1996) 1.01
Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun. Proc Natl Acad Sci U S A (1990) 0.99
Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells. Nucleic Acids Res (1990) 0.99
Isolation of human cDNA clones of jun-related genes, jun-B and jun-D. Nucleic Acids Res (1990) 0.97
Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53. Mol Cell Biol (2004) 0.97
Transcriptional control of c-jun by retinoic acid. Nucleic Acids Res (1991) 0.97
Regulation of c-jun expression during hypoxic and low-glucose stress. Mol Cell Biol (1994) 0.96
v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity. Mol Cell Biol (2000) 0.96
Jaagsiekte sheep retrovirus biology and oncogenesis. Viruses (2010) 0.96
Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1 beta or serum follow c-jun expression and are dependent on new protein synthesis. J Clin Invest (1989) 0.96
Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF. Mol Cell Biol (1996) 0.93
Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers. J Virol (1989) 0.93
Differentiation of F9 embryonal carcinoma cells induced by the c-jun and activated c-Ha-ras oncogenes. Proc Natl Acad Sci U S A (1990) 0.93
Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation. Cancer Res (2009) 0.91
Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family. Proc Natl Acad Sci U S A (1995) 0.91
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. Mol Cell Biol (1989) 0.90
Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function. Mol Pharmacol (2009) 0.90
Differential roles for Fos and Jun in DNA-binding: redox-dependent and independent functions. Nucleic Acids Res (1993) 0.87
Drosophila homolog of the mammalian jun oncogene is expressed during embryonic development and activates transcription in mammalian cells. Proc Natl Acad Sci U S A (1990) 0.86
JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis. Proc Natl Acad Sci U S A (2001) 0.85
c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard. Oncotarget (2011) 0.85
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. Br J Cancer (2008) 0.85
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy. Nat Commun (2016) 0.84
Transformation of chicken embryo fibroblasts by direct DNA transfection of single oncogenes: comparative analyses of src, erbB, myc, and ras. J Virol (1990) 0.84
JunD mutants with spontaneously acquired transforming potential have enhanced transactivating activity in combination with Fra-2. Proc Natl Acad Sci U S A (1993) 0.83
Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera. Proc Natl Acad Sci U S A (1997) 0.82
Adenovirus transcriptional regulatory regions are conserved in mammalian cells and Saccharomyces cerevisiae. Mol Cell Biol (1988) 0.82
Effect of PTTG on endogenous gene expression in HEK 293 cells. BMC Genomics (2009) 0.81
Pleiotropic derepression of developmentally regulated cellular and viral genes by c-myc protooncogene products in undifferentiated embryonal carcinoma cells. Nucleic Acids Res (1989) 0.81
Cooperation of v-jun and v-erbB oncogenes in embryo fibroblast transformation in vitro and in vivo. J Virol (1990) 0.80
Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases. Mol Cell Biol (1993) 0.80
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Screening lambdagt recombinant clones by hybridization to single plaques in situ. Science (1977) 83.82
Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76
A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res (1976) 24.00
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
"Nonrandom" DNA sequence analysis in bacteriophage M13 by the dideoxy chain-termination method. Proc Natl Acad Sci U S A (1982) 5.90
DNA sequence analysis by primed synthesis. Methods Enzymol (1980) 4.75
Isolation of three new avian sarcoma viruses: ASV 9, ASV 17, and ASV 25. Virology (1985) 1.60
Cooperative and antagonistic interactions among RNA tumor viruses. Natl Cancer Inst Monogr (1968) 1.19
Improving chronic illness care: translating evidence into action. Health Aff (Millwood) (2001) 22.31
Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol (2001) 14.57
Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science (1987) 10.25
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature (1976) 9.81
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell (1978) 7.46
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv (2001) 6.59
Fos-associated protein p39 is the product of the jun proto-oncogene. Science (1988) 6.34
Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology (1969) 6.24
Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis. Virology (1977) 5.90
Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses. Virology (1971) 5.75
Gel electrophoresis of avian leukosis and sarcoma viral RNA in formamide: comparison with other viral and cellular RNA species. J Virol (1973) 5.70
Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc Natl Acad Sci U S A (1987) 5.06
Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses. Proc Natl Acad Sci U S A (1970) 4.91
RNA species obtained from clonal lines of avian sarcoma and from avian leukosis virus. Virology (1973) 4.73
Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses. Virology (1973) 4.56
A randomized trial of a consultation service to reduce falls in nursing homes. JAMA (1997) 4.55
Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens. Virology (1965) 4.27
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med (1991) 4.23
Integration of deoxyribonucleic acid specific for Rous sarcoma virus after infection of permissive and nonpermissive hosts. Proc Natl Acad Sci U S A (1973) 4.19
A survey of leading chronic disease management programs: are they consistent with the literature? Manag Care Q (1999) 4.04
Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol (1996) 3.98
Glycoprotein components of avian and murine RNA tumor viruses. Virology (1970) 3.92
Class I PI3K in oncogenic cellular transformation. Oncogene (2008) 3.90
A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev (1999) 3.88
Characteristics of two new avian tumor virus subgroups. Virology (1969) 3.81
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (1997) 3.73
An avian leukosis virus related to RSV(O): properties and evidence for helper activity. Virology (1971) 3.68
Injuries of basal ganglia following head trauma in children. Childs Brain (1980) 3.67
The RNA of avian acute leukemia virus MC29. Proc Natl Acad Sci U S A (1977) 3.60
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A (2000) 3.40
Reversion from transformed to normal phenotype by inhibition of protein synthesis in rat kidney cells infected with a temperature-sensitive mutant of Rous sarcoma virus. Proc Natl Acad Sci U S A (1976) 3.38
The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology (1998) 3.35
Only one quarter of women with learning disability in Exeter have cervical screening. BMJ (1998) 3.33
Appearance of virus-specific DNA in mammalian cells following transformation by Rous sarcoma virus. J Mol Biol (1973) 3.21
DEAE-dextran: enhancement of cellular transformation induced by avian sarcoma viruses. Virology (1967) 3.20
Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol (1981) 3.18
Patterns of viral interference in the avian leukosis and sarcoma complex. Virology (1966) 3.12
Genetically stable reassortment of markers during mixed infection with avian tumor viruses. Virology (1971) 3.05
Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol (2001) 3.03
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci U S A (2001) 3.01
Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. Virology (1971) 3.00
The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci U S A (1998) 2.99
High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures. J Virol (1978) 2.96
Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ (2001) 2.85
Temperature sensitive mutants of an avian sarcoma virus. Virology (1969) 2.73
Localization of avian tumor virus group-specific antigen in cell and virus. Virology (1966) 2.70
Immunological relationships among envelope antigens of avian tumor viruses. Virology (1966) 2.67
Two new S-phase-specific genes from Saccharomyces cerevisiae. Yeast (1997) 2.64
A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet (1993) 2.64
Preventing disability and managing chronic illness in frail older adults: a randomized trial of a community-based partnership with primary care. J Am Geriatr Soc (1998) 2.62
Avian tumor viruses. Adv Virus Res (1965) 2.58
A virus released by "nonproducing" Rous sarcoma cells. Proc Natl Acad Sci U S A (1967) 2.52
NH2-terminal hydrophobic region of influenza virus neuraminidase provides the signal function in translocation. Proc Natl Acad Sci U S A (1984) 2.50
Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. Genes Dev (1990) 2.46
RNA of replication-defective strains of Rous sarcoma virus. Proc Natl Acad Sci U S A (1975) 2.37
Avian RNA tumor viruses: mechanism of recombination and complexity of the genome. Cold Spring Harb Symp Quant Biol (1975) 2.37
Properties of mammalian cells transformed by temperature-sensitive mutants of avian sarcoma virus. Cell (1977) 2.36
Rapid assessment of health status and preventive-medicine needs of newly arrived Kampuchean refugees, Sa Kaeo, Thailand. Lancet (1980) 2.34
Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc Natl Acad Sci U S A (2003) 2.34
jun: oncogene and transcription factor. Adv Cancer Res (1990) 2.32
Distribution of envelope-specific and sarcoma-specific nucleotide sequences from different parents in the RNAs of avian tumor virus recombinants. Proc Natl Acad Sci U S A (1976) 2.32
v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell (1988) 2.31
Electron microscope studies of tumor virus RNA. Cold Spring Harb Symp Quant Biol (1975) 2.30
The defectiveness of Mill Hill 2, a carcinoma-inducing avian oncovirus. Virology (1978) 2.26
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol (2001) 2.25
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: evidence for a second class of transforming genes. Proc Natl Acad Sci U S A (1979) 2.16
Paralysis of Deglutition: Surgical Correction. Ann Surg (1948) 2.12
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol (1999) 2.06
Risks of manipulation. J R Soc Med (1994) 2.05
Mapping oligonucleotides of Rous sarcoma virus RNA that segregate with polymerase and group-specific antigen markers in recombinants. Proc Natl Acad Sci U S A (1976) 2.04
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. Virology (1981) 2.03
Restitution of fibroblast-transforming ability in src deletion mutants of avian sarcoma virus during animal passage. Virology (1979) 1.93
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood (2001) 1.92
Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS (2000) 1.92
Effects of genetic cellular resistance on cell transformation and virus replication in chicken hematopoietic cell cultures infected with avian myeloblastosis virus (BAI-A). Virology (1968) 1.88
Unilateral neglect is more severe and common in older patients with right hemispheric stroke. Neurology (2008) 1.82
Studies on microperoxisomes. II. A cytochemical method for light and electron microscopy. J Histochem Cytochem (1972) 1.82
Premature labor. II. Bacterial sources of phospholipase. Obstet Gynecol (1981) 1.81
Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken. Virology (1965) 1.81
Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci U S A (1999) 1.81
Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem (2000) 1.77
Ts pol mutants of avian sarcoma viruses: mapping and demonstration of single cycle recombinants. Virology (1978) 1.74
The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J Biol Chem (2000) 1.71
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol (1989) 1.70
Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene (2001) 1.70
The terminal oligonucleotides of avian tumor virus RNAs are genetically linked. Virology (1977) 1.70
Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells. Mol Cell Biol (1985) 1.69
Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc Natl Acad Sci U S A (1999) 1.69
Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. Proc Natl Acad Sci U S A (1979) 1.68
Envelope classification of avian RNA tumor viruses. Bibl Haematol (1970) 1.67